Early response monitoring of receptor tyrosine kinase inhibitor therapy in metastatic renal cell carcinoma using [F-18]fluorothymidine-positron emission tomography-magnetic resonance.
Publication
, Journal Article
Valls, L; Hoimes, C; Sher, A; Hu, L; Lee, Z; Muzic, R; Avril, N
Published in: Semin Roentgenol
July 2014
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Semin Roentgenol
DOI
EISSN
1558-4658
Publication Date
July 2014
Volume
49
Issue
3
Start / End Page
238 / 241
Location
United States
Related Subject Headings
- Tyrosine
- Treatment Outcome
- Tomography, X-Ray Computed
- Sunitinib
- Radiopharmaceuticals
- Pyrroles
- Protein Kinase Inhibitors
- Positron-Emission Tomography
- Nuclear Medicine & Medical Imaging
- Multimodal Imaging
Citation
APA
Chicago
ICMJE
MLA
NLM
Valls, L., Hoimes, C., Sher, A., Hu, L., Lee, Z., Muzic, R., & Avril, N. (2014). Early response monitoring of receptor tyrosine kinase inhibitor therapy in metastatic renal cell carcinoma using [F-18]fluorothymidine-positron emission tomography-magnetic resonance. Semin Roentgenol, 49(3), 238–241. https://doi.org/10.1053/j.ro.2014.09.001
Valls, Laia, Christopher Hoimes, Andrew Sher, Lingzhi Hu, Zhenghong Lee, Raymond Muzic, and Norbert Avril. “Early response monitoring of receptor tyrosine kinase inhibitor therapy in metastatic renal cell carcinoma using [F-18]fluorothymidine-positron emission tomography-magnetic resonance.” Semin Roentgenol 49, no. 3 (July 2014): 238–41. https://doi.org/10.1053/j.ro.2014.09.001.
Valls L, Hoimes C, Sher A, Hu L, Lee Z, Muzic R, et al. Early response monitoring of receptor tyrosine kinase inhibitor therapy in metastatic renal cell carcinoma using [F-18]fluorothymidine-positron emission tomography-magnetic resonance. Semin Roentgenol. 2014 Jul;49(3):238–41.
Valls, Laia, et al. “Early response monitoring of receptor tyrosine kinase inhibitor therapy in metastatic renal cell carcinoma using [F-18]fluorothymidine-positron emission tomography-magnetic resonance.” Semin Roentgenol, vol. 49, no. 3, July 2014, pp. 238–41. Pubmed, doi:10.1053/j.ro.2014.09.001.
Valls L, Hoimes C, Sher A, Hu L, Lee Z, Muzic R, Avril N. Early response monitoring of receptor tyrosine kinase inhibitor therapy in metastatic renal cell carcinoma using [F-18]fluorothymidine-positron emission tomography-magnetic resonance. Semin Roentgenol. 2014 Jul;49(3):238–241.
Published In
Semin Roentgenol
DOI
EISSN
1558-4658
Publication Date
July 2014
Volume
49
Issue
3
Start / End Page
238 / 241
Location
United States
Related Subject Headings
- Tyrosine
- Treatment Outcome
- Tomography, X-Ray Computed
- Sunitinib
- Radiopharmaceuticals
- Pyrroles
- Protein Kinase Inhibitors
- Positron-Emission Tomography
- Nuclear Medicine & Medical Imaging
- Multimodal Imaging